Review ArticleReviewsR

The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice

LUBOS HOLUBEC, JIRI POLIVKA, LENKA LISNEROVA, TEREZA KUBIKOVA and MARTIN SAFANDA
In Vivo May 2017, 31 (3) 303-306;

Article Information

vol. 31 no. 3 303-306
PubMed 
28438855
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received February 6, 2017
  • Revision received March 9, 2017
  • Accepted March 10, 2017
  • Published online April 24, 2017.
Copyright & Usage 
Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. LUBOS HOLUBEC1,2,
  2. JIRI POLIVKA1,3,4⇑,
  3. LENKA LISNEROVA2,
  4. TEREZA KUBIKOVA1,3 and
  5. MARTIN SAFANDA2
  1. 1Biomedical Center, Faculty of Medicine in Plzen, Charles University, Pilsen, Czech Republic
  2. 2Department of Clinical Oncology, Na Homolce Hospital, Prague, Czech Republic
  3. 3Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic
  4. 4Department of Neurology, Faculty Hospital Plzen, Pilsen, Czech Republic
  1. Correspondence to: Jiri Polivka, Biomedical Center, Department of Histology and Embryology, Faculty of Medicine in Plzen, Charles University, Husova 3, 301 66, Plzen, Czech Republic. Tel: +420 377593320, e-mail: polivkajiri{at}gmail.com
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice
LUBOS HOLUBEC, JIRI POLIVKA, LENKA LISNEROVA, TEREZA KUBIKOVA, MARTIN SAFANDA
In Vivo May 2017, 31 (3) 303-306;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords